Now that we have passed through another divisive election, we can think about other issues. The month of November has been designated as Movember as a tool to remind men about their health issues including prostate cancer and testicular cancer, but also mental health issues like anxiety and depression.
Now that men have had a few weeks to grow beards and goatees to show off Movember manliness, let’s think about the role of a man. A bearded man riding a 30-foot wave on a surfboard seems very macho, but the reality of being a man should also include taking care of the people you love. In order to do that properly, they need to be in their best physical and mental state. Men need to take care of themselves and in some cases need help in doing so.
Typically in this month we focus on prostate and testicular cancer, but we also have to consider the very dark side of depression and anxiety. As we entire the final week of November, and the burden of holidays and parties and expectations fast approaches in December, it’s never a better time to reflect on this topic.
Men have many choices in addressing anxiety and depression. They can deny its existence or treat it with:
Some of these options can delay improvement or worsen the depression. Others may improve the symptoms and the depression itself. Some are done under the guidance of a health care provider and others are performed with self-medication/regulation.
Previously cannabis was used primarily as a self-regulating medication without the help of outside guidance. The dosages were variable as were the responses. Medical marijuana allowed for greater study, however we still don’t have complete information regarding dosage, type of cannabis, percentage of improved patients and side effects. We do have a great amount of knowledge about the anecdotal improvement in PTSD. We need further studies to evaluate improvement, dosage and side effects.
We know in smaller dosage anxiety can be lessened and in larger doses it can worsen anxiety. But where is the cut off point? This probably differs for each person based upon physical size, type of chemical imbalance, and pharmacodynamics. Do we even know what chemical imbalance the cannabis treats? We need a fuller understanding of the pharmacokinetics of the types of cannabis and their interactions in order to determine dosage on a scientific, rather than anecdotal, basis. We have to make sure that there is quality control from company to company to make sure they are all selling equal medications or that we understand the differences.
Treating anxiety and depression is difficult and generally has a better success rate with a combination of psychotherapy. It is a difficult and slow processes because we are trying to unwrap old problems while the patient is given new issues on a daily basis. The medications, whether pharmaceuticals or cannabinoids, are absorbed at different rates with an effect within minutes to hours.
Since much of the treatment includes self-regulation of therapy, it can be difficult on a day-to-day basis to determine the correct dosage with all the variabilities of absorption, types of medications and outside influences.
Cannabis can improve the lives of those suffering from anxiety and depression. We need more clinical studies to determine how we can make this type of treatment more effective.